Hyloris Pharmaceuticals SaEURONEXT: HYL

Licenses European and Turkish Rights to Next-Generation Wilson’s Disease Candidate from ArborMed

Dec 30, 2025 at 5:33 PM UTC · Issued by Hyloris Pharmaceuticals SA

30 Dec 2025 18:20 CET

Subscribe

Issuer

HYLORIS PHARMACEUTICALS SA

pressreleasehylorisarbormedlicense-european-rightswilson-diseasefinalen20251230.pdf

Source

HYLORIS

Provider

Euronext

Company Name

HYLORIS

ISIN

BE0974363955

Symbol

HYL

Market

Euronext

Earlier from Hyloris Pharmaceuticals Sa

All Hyloris Pharmaceuticals Sa news releases